248 related articles for article (PubMed ID: 31522287)
61. GATA3 Regulates the Development and Functions of Innate Lymphoid Cell Subsets at Multiple Stages.
Zhu J
Front Immunol; 2017; 8():1571. PubMed ID: 29184556
[TBL] [Abstract][Full Text] [Related]
62. An Id2
Xu W; Cherrier DE; Chea S; Vosshenrich C; Serafini N; Petit M; Liu P; Golub R; Di Santo JP
Immunity; 2019 Apr; 50(4):1054-1068.e3. PubMed ID: 30926235
[TBL] [Abstract][Full Text] [Related]
63. Increased prevalence of lymphoid tissue inducer cells in the cerebrospinal fluid of patients with early multiple sclerosis.
Degn M; Modvig S; Dyring-Andersen B; Bonefeld CM; Frederiksen JL; Geisler C; von Essen MR
Mult Scler; 2016 Jul; 22(8):1013-20. PubMed ID: 26453677
[TBL] [Abstract][Full Text] [Related]
64. Innate lymphoid cells in secondary lymphoid organs.
Bar-Ephraïm YE; Mebius RE
Immunol Rev; 2016 May; 271(1):185-99. PubMed ID: 27088915
[TBL] [Abstract][Full Text] [Related]
65. The transcription factor Bcl11b is specifically expressed in group 2 innate lymphoid cells and is essential for their development.
Yu Y; Wang C; Clare S; Wang J; Lee SC; Brandt C; Burke S; Lu L; He D; Jenkins NA; Copeland NG; Dougan G; Liu P
J Exp Med; 2015 Jun; 212(6):865-74. PubMed ID: 25964371
[TBL] [Abstract][Full Text] [Related]
66. Human innate lymphoid cells (ILCs): Toward a uniform immune-phenotyping.
Trabanelli S; Gomez-Cadena A; Salomé B; Michaud K; Mavilio D; Landis BN; Jandus P; Jandus C
Cytometry B Clin Cytom; 2018 May; 94(3):392-399. PubMed ID: 29244250
[TBL] [Abstract][Full Text] [Related]
67. Mouse models for the study of fate and function of innate lymphoid cells.
Cording S; Medvedovic J; Lécuyer E; Aychek T; Déjardin F; Eberl G
Eur J Immunol; 2018 Aug; 48(8):1271-1280. PubMed ID: 29974461
[TBL] [Abstract][Full Text] [Related]
68. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
Kato N; Yasukawa K; Onozuka T; Kikuta H
J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
[TBL] [Abstract][Full Text] [Related]
69. T-bet and Gata3 in controlling type 1 and type 2 immunity mediated by innate lymphoid cells.
Hoyler T; Connor CA; Kiss EA; Diefenbach A
Curr Opin Immunol; 2013 Apr; 25(2):139-47. PubMed ID: 23490163
[TBL] [Abstract][Full Text] [Related]
70. CD56 Expression Marks Human Group 2 Innate Lymphoid Cell Divergence from a Shared NK Cell and Group 3 Innate Lymphoid Cell Developmental Pathway.
Chen L; Youssef Y; Robinson C; Ernst GF; Carson MY; Young KA; Scoville SD; Zhang X; Harris R; Sekhri P; Mansour AG; Chan WK; Nalin AP; Mao HC; Hughes T; Mace EM; Pan Y; Rustagi N; Chatterjee SS; Gunaratne PH; Behbehani GK; Mundy-Bosse BL; Caligiuri MA; Freud AG
Immunity; 2018 Sep; 49(3):464-476.e4. PubMed ID: 30193847
[TBL] [Abstract][Full Text] [Related]
71. Innate lymphoid cells in normal and disease: An introductory overview.
Moretta L; Locatelli F
Immunol Lett; 2016 Nov; 179():1. PubMed ID: 27400678
[TBL] [Abstract][Full Text] [Related]
72. Phenotype of recovering lymphoid cell populations after marrow transplantation.
Ault KA; Antin JH; Ginsburg D; Orkin SH; Rappeport JM; Keohan ML; Martin P; Smith BR
J Exp Med; 1985 Jun; 161(6):1483-502. PubMed ID: 3159819
[TBL] [Abstract][Full Text] [Related]
73. Transcriptional and epigenetic networks of helper T and innate lymphoid cells.
Shih HY; Sciumè G; Poholek AC; Vahedi G; Hirahara K; Villarino AV; Bonelli M; Bosselut R; Kanno Y; Muljo SA; O'Shea JJ
Immunol Rev; 2014 Sep; 261(1):23-49. PubMed ID: 25123275
[TBL] [Abstract][Full Text] [Related]
74. Helper-like innate lymphoid cells and cancer immunotherapy.
Crinier A; Vivier E; Bléry M
Semin Immunol; 2019 Feb; 41():101274. PubMed ID: 31072659
[TBL] [Abstract][Full Text] [Related]
75. Type 1 innate lymphoid cells contribute to the pathogenesis of chronic hepatitis B.
Yang Z; Tang T; Wei X; Yang S; Tian Z
Innate Immun; 2015 Aug; 21(6):665-73. PubMed ID: 25977358
[TBL] [Abstract][Full Text] [Related]
76. Tumor-infiltrating lymphocytes isolated from a Ki-1-positive large cell lymphoma of the skin. Phenotypic characterization and analysis of cytokine secretion.
Reinhold U; Abken H; Kukel S; Goeden B; Uerlich M; Neumann U; Kreysel HW
Cancer; 1991 Nov; 68(10):2155-60. PubMed ID: 1655203
[TBL] [Abstract][Full Text] [Related]
77. A three course menu for ILC and bystander T cell activation.
McGinty JW; von Moltke J
Curr Opin Immunol; 2020 Feb; 62():15-21. PubMed ID: 31830683
[TBL] [Abstract][Full Text] [Related]
78. Transcriptional control of innate lymphoid cells.
Mjösberg J; Bernink J; Peters C; Spits H
Eur J Immunol; 2012 Aug; 42(8):1916-23. PubMed ID: 22865043
[TBL] [Abstract][Full Text] [Related]
79. Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma.
Richendollar BG; Pohlman B; Elson P; Hsi ED
Hum Pathol; 2011 Apr; 42(4):552-7. PubMed ID: 21237493
[TBL] [Abstract][Full Text] [Related]
80. Abortive γδTCR rearrangements suggest ILC2s are derived from T-cell precursors.
Shin SB; Lo BC; Ghaedi M; Scott RW; Li Y; Messing M; Hernaez DC; Cait J; Murakami T; Hughes MR; Leslie KB; Underhill TM; Takei F; McNagny KM
Blood Adv; 2020 Nov; 4(21):5362-5372. PubMed ID: 33137203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
